Synthesis Health
synthesishealth.com
Actively hiring
Follow
Overview
Technologies
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$57.1M
3 rounds on record
Latest round
$23.8M
Venture round · Jul 2025 · 14 mo ago
Team
51-200
employees, estimated range
Revenue
$25M
2025 · SEC Form D 0002040850-26-000001
The money's age
Due for its next round
14 months since the last round · not hiring
Momentum
10/100
a new city
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 5
Board appointment Jeffrey Natland, Director · SEC Form D
Jul 25, 2025
Raised a round Venture round $23.8M · SEC Form D
May 10, 2024
Raised a round Venture round $9.5M · SEC Form D
2023
Founded
Tractionpublic signals, read monthly
Web presence
top 57%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2025 | $23.8M | — | SEC Form D |
| Venture round | Jul 2025 | $23.8M | — | SEC Form D |
| Venture round | May 2024 | $9.5M | — | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Josh KaecheleExecutive OfficerSEC Form D
Murray ReicherExecutive Officer, DirectorSEC Form D
Deepak KauraExecutive OfficerSEC Form D
Jesse WakleyExecutive OfficerSEC Form D
Amy GilchristExecutive OfficerSEC Form D
Francois Van HoutenExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation.
Kingdom creates clinically validated Superculture ingredients from natural microbes to improve the health of pets and people. It describes…
Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly…
A gene therapy approach to treating chronic, age-related disease. Targeting the root causes of aging to create life-changing treatments for…
For decades, LICORbio has developed fluorescence imaging technologies to address the needs of the scientific community.
Resolve AI handles all alerts, performs root cause analysis, and troubleshoots incidents within minutes.
Tech stack
Technologies named in job postings at Synthesis Health over the last 12 months, by layer, with the share of postings for each.
Technologies in use
3
Postings analysed
2
Stack modernity
78/100
Languages
SQL
Cloud & platforms
GCP
Grafana
Sign in to see how your skills match this stack
Sign In
People
Josh Kaechele
Executive Officer
Murray Reicher
Executive Officer, Director
Deepak Kaura
Executive Officer
Jesse Wakley
Executive Officer
Amy Gilchrist
Executive Officer
Francois Van Houten
Executive Officer, Director
Gupta Ridhi
Executive Officer
Joshua Kaechele
Executive Officer
William Bennett
Director
Landon Downs
Director
Jeffrey Natland
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
33/100
Slowing
Open positions
0
0 opened / 3 closed in 30 days
Median time-to-fill
42 days
faster than 31% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Support
67% ▲
Finance
33% ▼
Activity Timeline
New location: Houston
Sep 2026
Added Microsoft Office to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
3
Hiring now
0
Countries
3
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Dubai
United Arab Emirates
HQ
Houston
United States
Regional office
Houston
1 posted in 90 days 50-200 est. staff
Vancouver
Canada
Regional office
Vancouver
Financials
Est. Annual Revenue
$15M
2025
Total raised
$57.1M
Latest round
Venture - Series Unknown
Funding rounds
3
Revenue
0% YoY
Estimate
Low-high range
Modelled from public signals, not audited accounts - read it as an order of magnitude.
| Year | Estimate | Low | High |
|---|---|---|---|
| 2023 | $15M | $5M | $25M |
| 2024 | $15M | $5M | $25M |
| 2025 | $15M | $5M | $25M |